BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3592119)

  • 1. N-myc oncogene amplification in a patient with IV-S neuroblastoma.
    Tonini GP; Verdona G; De Bernardi B; Sansone R; Massimo L; Cornaglia-Ferraris P
    Am J Pediatr Hematol Oncol; 1987; 9(1):8-10. PubMed ID: 3592119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
    Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma.
    Garvin J; Bendit I; Nisen PD
    Cancer; 1990 Jun; 65(11):2572-5. PubMed ID: 1692506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K; Okabe T
    J Pediatr Surg; 1987 May; 22(5):415-8. PubMed ID: 3585663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of oncogene activation in human neuroblastomas.
    Brodeur GM; Seeger RC; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    Cancer; 1986 Jul; 58(2 Suppl):541-5. PubMed ID: 3719548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.
    Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
    J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-myc amplification in an infant with stage IVS neuroblastoma.
    Cohn SL; Herst CV; Maurer HS; Rosen ST
    J Clin Oncol; 1987 Sep; 5(9):1441-4. PubMed ID: 3625259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc oncogene RNA expression in neuroblastoma.
    Nisen PD; Waber PG; Rich MA; Pierce S; Garvin JR; Gilbert F; Lanzkowsky P
    J Natl Cancer Inst; 1988 Dec; 80(20):1633-7. PubMed ID: 2461451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
    Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
    Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols.
    Combaret V; Wang Q; Favrot MC; Thiesse P; Philip I; Bouffet E; Bailly C; Bouvier R; Chauvin F; Zucker JM
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1607-12. PubMed ID: 2591453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
    Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.
    Tsuda T; Obara M; Hirano H; Gotoh S; Kubomura S; Higashi K; Kuroiwa A; Nakagawara A; Nagahara N; Shimizu K
    Cancer; 1987 Aug; 60(4):820-6. PubMed ID: 3594401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc oncogene amplification and prognostic factors of neuroblastoma in children.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K
    J Pediatr Surg; 1987 Oct; 22(10):895-8. PubMed ID: 3316592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations].
    Dahbiová R; Kodet R; Soukup J; Kavan P; Smelhaus V; Koutecký J
    Cesk Patol; 1997 Aug; 33(3):83-8. PubMed ID: 9471397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
    Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
    Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.